Loading...

4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

Alzheimer's Association International Conference 2026

July 12-15, 2026 | London, United Kingdom, and Online

Alzheimer's Association International Conference 2026 banner

7257

Setting Population-based Blood Pressure Guidelines For Alzheimer's Disease And Related Dementia Study Participants In American Samoa.

Part of Topic

Setting blood pressure guidelines for an Alzheimer's Disease and Related Dementia Study for American Samoans. Grace-Damona Tuato’o, Tulimalefoi Mauga Vaofanua, Fenumia’i Iosia, Helen Aitaoto, Katherine Tong, Joyce Niko, James Galvin, Va’atausili Tofaeono

Culturally grounded protocols allow for improved inclusivity in research participation forindigenous populations.

Background: Native Hawaiian and Pacific Islanderspopulations are underrepresented in Alzheimer’s Disease and Related Dementia (ADRD) research,limiting the generalizability and equity of theevidence base. National data sources illustrate thisgap. In American Samoa, 58.4% of adults aged 65years and older have hypertension, a recognizedvascular risk factor for ADRD. However,standardized blood pressure (BP) screeningthresholds derived from predominantly non-Indigenous populations may inadvertently excludeindividuals at highest vascular risk from ADRDstudies. Standards from the American HeartAssociation in table 1 were used to inform programprocedures but it introduced selection bias andlimited the ability to examine vascular contributionsto cognitive impairment. The team hypothesized thatby modifying program protocols through combiningWesternized and Indigenous frameworks, it willimprove inclusivity of the Samoan population inADRD studies and maintain participant safety.

Method: We conducted a data-informed,consensus-driven evaluation of BP screeningprocedures used inthePuipui MaluManatu(PMM) study (RF1AG075904).Thestructured consensus group consisted ofPMM’s Principal Investigator, nursing staff,and research coordinators who revieweddescriptive BP data from794 PMMparticipants. BP measurements weresummarized overall across age groups (Table2).

Averages across groups were then used toinform protocol decisions relevant to olderadults (Table 3).The consensus processincorporated Indigenous and community-centered decision-making frameworks,including Two-Eyed Seeing and Talanoa, tointegrate empirical data with culturallygrounded norms.

Results: Based on these findings, theconsensus was to revise study protocol todiscontinue reliance on non-population-specific BP exclusion thresholds. Instead,enhanced monitoring and clinical oversightprocedures were implemented to supportsafe inclusion of older adults and individualswith hypertension. Table 4 shows theupdated number of participants following theprotocol modifications, with an additional163 participants from December 2025, withTable 5 displaying the averages across theage groups.

 

Updated protocol:

 

  • BP exclusion criteria modified:

  • > 180/100 & symptomatic? YES:Reschedule with ED referral. If NO: AMAand continue visit.

  • >200/120 & asymptomatic - Bed patientfor 15 minutes and retake BP. If persists

  • >200/120 reschedule with ED referral.

Conclusion: Data-informed, culturallygrounded protocol modification in the PMMstudy reduced selection bias and improvedinclusivity. This approach provides a scalablemodel for improving equity and scientific rigorin ADRD research involving Indigenous andother high-risk populations globally.

References:
American Heart Association. (n.d.). What is high blood pressure? | American Heart Association. What is High Blood Pressure? https://www.heart.org/en/health-topics/high-blood-pressure/the-facts-about-high-blood-pressure

Contact:
Grace Tuato’o

Research Assistant

American Samoa Community Cancer Coalition

Phone: (206)-519-2925


Comments

Email is required but is not shown publicly.

Loading comments...

aaic2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.